Table 2.
Patient characteristics by COVID-19 vaccination status.
| Clinical and demographic parameter | Characteristic | Fully vaccinated, n = 143 (71%) | Partially vaccinated, n = 26 (13%) | Unvaccinated, n = 33 (16%) | p-value | |
|---|---|---|---|---|---|---|
| Age | 18–25 | 5 (3.5) | 1 (3.9) | 1 (3.0) | 6.884 | 0.331 |
| 26–40 | 13 (9.1) | 5 (19.2) | 7 (21.2) | |||
| 41–64 | 78 (54.5) | 15 (57.7) | 18 (54.6) | |||
| ≥65 | 47 (32.9) | 5 (19.2) | 7 (21.2) | |||
| Sex | Male | 57 (39.9) | 15 (57.7) | 12 (36.4) | 3.322 | 0.189 |
| Female | 86 (60.1) | 11 (42.3) | 21 (63.6) | |||
| Education | With academic degree | 89 (62.2) | 15 (57.7) | 19 (57.6) | 0.372 | 0.829 |
| Without academic degree | 54 (37.8) | 11 (42.3) | 14 (42.4) | |||
| Marital status | Single | 13 (9.1) | 4 (15.4) | 3 (9.1) | 4.814 | 0.567 |
| Married | 103 (72.0) | 17 (65.4) | 21 (63.6) | |||
| Divorced | 15 (10.5) | 2 (7.7) | 7 (21.2) | |||
| Widowed | 12 (8.4) | 3 (11.5) | 2 (6.1) | |||
| Living area | Urban area | 106 (74.1) | 17 (65.4) | 24 (72.7) | 0.848 | 0.654 |
| Rural area | 37 (25.9) | 9 (34.6) | 9 (27.3) | |||
| Occupation and employment status | Employed | 83 (58.0) | 13 (50.0) | 19 (57.6) | 6.221 | 0.398 |
| Unemployed | 9 (6.3) | 3 (11.5) | 5 (15.2) | |||
| Retired | 40 (28.0) | 6 (23.1) | 8 (24.2) | |||
| Other | 11 (7.7) | 4 (15.4) | 1 (3.0) | |||
| Smartphone operating system | Android | 120 (83.9) | 24 (92.4) | 28 (84.8) | 9.263 | 0.055 |
| iOS | 23 (16.1) | 1 (3.8) | 5 (15.2) | |||
| Other | 0 (0) | 1 (3.8) | 0 (0) | |||
| Cancer type | Breast | 27 (18.9) | 1 (3.8) | 5 (15.2) | 33.33 | 0.015 |
| Cervix | 17 (11.9) | 4 (15.4) | 11 (33.3) | |||
| Prostate | 18 (12.5) | 3 (11.5) | 5 (15.1) | |||
| Digestive tract | 17 (11.9) | 3 (11.5) | 3 (9.1) | |||
| Lungs | 12 (8.4) | 3 (11.5) | 2 (6.1) | |||
| Uterus | 14 (9.8) | 1 (3.8) | 1 (3.0) | |||
| Hematological | 15 (10.5) | 1 (3.8) | 1 (3.0) | |||
| Mouth | 6 (4.2) | 1 (3.8) | 2 (6.1) | |||
| Other | 17 (11.9) | 9 (34.6) | 3 (9.1) | |||
| History of COVID-19 | Yes | 53 (37.1) | 12 (46.2) | 20 (60.6) | 6.3 | 0.042 |
| No | 90 (62.9) | 14 (53.8) | 13 (39.4) | |||
| History of cancer surgery | Yes | 65 (45.5) | 11 (42.3) | 10 (30.3) | 2.518 | 0.283 |
| No | 78 (54.5) | 15 (57.7) | 23 (69.7) | |||
| History of biological therapy | Yes | 13 (9.1) | 3 (11.5) | 1 (3.0) | 1.655 | 0.437 |
| No | 130 (90.9) | 23 (88.5) | 32 (97.0) | |||
| History of chemotherapy | Yes | 55 (38.5) | 7 (26.9) | 7 (21.2) | 4.241 | 0.119 |
| No | 88 (61.5) | 19 (73.1) | 26 (78.8) | |||
| History of hormone treatment | Yes | 19 (13.3) | 3 (11.5) | 5 (15.2) | 0.166 | 0.92 |
| No | 124 (86.7) | 23 (88.5) | 28 (84.8) | |||
| History of immunotherapy | Yes | 8 (5.6) | 3 (11.5) | 0 (0) | 3.781 | 0.151 |
| No | 135 (94.4) | 23 (88.5) | 33 (100.0) | |||
| Current chemotherapy | Yes | 74 (51.7) | 11 (42.3) | 17 (51.5) | 0.8 | 0.67 |
| No | 69 (48.3) | 15 (57.7) | 16 (48.5) | |||
| Current hormone treatment | Yes | 27 (18.9) | 3 (11.5) | 5 (15.2) | 0.958 | 0.619 |
| No | 116 (81.1) | 23 (88.5) | 28 (84.8) | |||
| Current biological therapy | Yes | 20 (14.0) | 4 (15.4) | 3 (9.1) | 0.659 | 0.718 |
| No | 123 (86.0) | 22 (84.6) | 30 (90.9) | |||
| Current immunotherapy | Yes | 8 (5.6) | 3 (11.5) | 1 (3.0) | 1.988 | 0.369 |
| No | 135 (94.4) | 23 (88.5) | 32 (97.0) | |||
| Current radiotherapy | Yes | 69 (48.3) | 12 (46.2) | 20 (60.6) | 1.813 | 0.403 |
| No | 74 (51.7) | 14 (53.8) | 13 (39.4) | |||
| Radiotherapy localization | Pelvis | 22 (31.9) | 2 (16.7) | 10 (50.0) | 20.336 | 0.404 |
| Prostate | 12 (27.5) | 1 (8.3) | 5 (25.0) | |||
| Lungs | 6 (8.7) | 2 (16.7) | 0 (0.0) | |||
| Breasts | 4 (5.7) | 1 (8.3) | 1 (5.0) | |||
| Head–neck | 3 (4.3) | 1 (8.3) | 2 (10.0) | |||
| Other | 22 (31.9) | 5 (47.7) | 2 (10.0) | |||
| Currently on cisplatin | Yes | 19 (13.3) | 4 (15.4) | 11 (33.3) | 5.944 | 0.051 |
| No | 124 (86.7) | 22 (84.6) | 22 (66.7) | |||
| ECOG | 0 | 123 (86.0) | 23 (88.5) | 31 (93.9) | 1.788 | 0.774 |
| 1 | 19 (13.3) | 3 (11.5) | 2 (6.1) | |||
| 2 | 1 (0.7) | 0 (0) | 0 (0) |
Bold values mean statistical significant differences.